Nordic Biomarker is a Swedish original manufacturer of latex reagents for coagulation and clinical chemistry analyzers.
Advanced Reagents for Coagulation Analyzers
Nordic Biomarker is the leading European OEM-supplier of advanced reagents for coagulation analyzers.
Nordic Biomarker is especially focused on development and manufacturing of latex immunoassays, for example reagents for testing of D-dimer, FDP and Free Protein S.
All production is performed in-house at Nordic Biomarker’s facility in Umeå, Sweden, with deliveries to OEM-clients around the world to be sold under their own brand names to hospital laboratories. Nordic Biomarker also collaborates closely with its OEM-clients to customize the products for specific instruments and to provide technical support.
Nordic Biomarker is continuously investing in research and development of new products, with current attention on reagents for Antithrombin, vWF, FM and Protein C.
With a growing product portfolio of specialty reagents for the coagulation laboratory, Nordic Biomarker is an interesting collaboration partner for any company seeking to supply the health-care sector with a complete coagulation/hemostasis reagent package.
Who we are
- Swedish original manufacturer of latex reagents for coagulation and clinical chemistry analyzers
- Serving OEM-clients around the world with customized solutions together with technical support
- Short lead-times and production against orders for maximized shelf-life
- Qualified and fast customer support from highly educated staff
- Continuously on-going research and development and a growing product portfolio
- Collaboration partner for companies seeking a complete hemostasis reagent package.
For the first time, Nordic Biomarker exhibited with their own booths at CACLP in Chongqing and ISTH in Dublin. Today, the next production facility into which the company will move in 2020, has also been conceived.
To meet the interest from the Asia market, after several years of research and development a latex reagent for Fibrin(ogen) Degradation Products (FDP) was released.
The CE-marked Red Free Protein S kit was released to the market.
Nordic Biomarker released the first Free Protein S in the world, available on an OEM-basis.
Nordic Biomarker invested in scaling-up production capacity to meet growing demands.
Nordic Biomarker CE-marked the Red and Blue D-dimer kits. In its strive to supply a wider range of specialty reagents for coagulation analyzers, the R&D-project for a Free Protein S Latex Immunoassay was initiated.
To meet the quality expectations from its OEM-partner’s, Nordic Biomarker had worked from the start to comply with applicable standards and regulatory requirements. This work was now awarded with the first ISO 13485 Certification.
During the early years, Nordic Biomarker was completely focused on developing and manufacturing D-dimer reagents. To serve a wider range of coagulation analyzers, Blue D-dimer was born.
Nordic Biomarker released its first product for sale. This was Red D-dimer, which it is still one of the company’s main products. The successful launch of Red D-dimer gave Nordic Biomarker the confidence to move into the same 1200 m2 production facility where it is still operating today.
Nordic Biomarker was founded by Dr. Gunnar Pohl and Dr. Göran Aronsson. After several years of experience from the IVD-industry, they had realized a market demand for an independent OEM-supplier of high-quality reagents for coagulation analyzers.
Right now we do not have any specific positions open for application, but we are always looking for talented and dedicated new colleagues.
If you are interested in working at Nordic Biomarker, please send your resume to firstname.lastname@example.org.
Nordic Biomarker complies with applicable harmonized standards, most notably ISO 13485:2016.
ISO 13485:2016 Certification
Nordic Biomarker representatives will be visiting Medlab in Dubai 4-7 February 2019.
Want us to stop by at your booth for a chat? Let us know: email@example.com.
Today Nordic Biomarker launched our new website and visual identity, a project we’ve been working with since the beginning of this year. Our ambition with the new website and visual identity is to clearly present Nordic Biomarker’s products and services, as well as the skills within the company. In addition, the goal is to offer the visitor a more visually appealing experience and responsive design. We hope you’ll enjoy it!
Har du en bakgrund inom biomedicin, biokemi eller kemi? Är du en problemlösare som visar prov på planeringsförmåga? Vi söker nu en självständig och strukturerad laboratorieingenjör till vårt fantastiska team i Umeå. Läs mer och ansök här!
Please visit us in Nordic Biomarker’s booth at the International Society on Thrombosis and Haemostasis (ISTH) 64th Annual Scientific and Standardization Committee (SSC) meeting in Dublin, Ireland on July 18-21, 2018. We would like to talk to you about how we can design our OEM-reagents for D-dimer, FDP, FPS, FM and vWF to run well on your coagualtion- or biochemsitry analyzer.
Nordic Biomarker has been ISO 13485 for many years, but now we have upgraded our Quality Management System to comply with the new 2016 version of ISO 13485. You can find our last ISO 13485-certficate here!
A new verion of Nordic Biomarker’s Guideline on how to design D-dimer applications is now available in a new version. Read it here!
Please visit us in Nordic Biomarker’s booth N7-S102 at CACLP EXPO in Chongqing March 17-19, 2018. We would like to talk to you about how we can design our OEM-reagents for D-dimer, FDP, FPS, FM and vWF to run well on your coagualtion- or biochemsitry analyzer. We will also be in this great city a few days before the exhibition starts, so there is also opportunity for you to ge a quite meeting with us in our hotel conference room during these days.
Nordic Biomarker will be present MEDLAB in Dubai February 5 – 8, 2018. If you would like to talk to us, please contact us in advance to set up a meeting. We would be happy to discuss new collaborations and coagulation products.
For the 10th year in a fow, Nordic Biomarker will be at Medica. There will be several people going representing managment, marketing and R&D. If you would like to meet any of us, please contact us in advance to set up an appointment.